Details

Autor(en) / Beteiligte

• Reddy, Chakravarthy B
• DeCamp, Malcolm M
• Diekemper, Rebecca L
• Gould, Michael K
• Henry, Travis
• Iyer, Narayan P
• Lee, Y C Gary
• Lewis, Sandra Z
• Maskell, Nick A
• Rahman, Najib M
• Sterman, Daniel H
• Wahidi, Momen M
• Balekian, Alex A
• Feller-Kopman, David J

Titel

Summary for Clinicians: Clinical Practice Guideline for Management of Malignant Pleural Effusions

Ist Teil von

• Annals of the American Thoracic Society, 2019-01, Vol.16 (1), p.17-21

Ort / Verlag

United States: American Thoracic Society

Erscheinungsjahr

2019

Link zum Volltext

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Because the average survival of patients with MPE is 4 to 7 months (3), treatment should aim to relieve dyspnea in a minimally invasive manner and prevent the need for multiple procedures. The use of ultrasound guidance reduced the risk of pneumothorax after thoracentesis for malignant effusions (1.0% vs. 8.9%; relative risk [RR], 0.10; 95% confidence interval [CI], 0.03-0.37). On the basis of the reduced length of hospital stay and low observed incidence of complications associated with IPCs, as well as abundant clinical experience that chemical pleurodesis is rarely effective in the setting of nonexpandable lung, the panel recommended IPCs over chemical pleurodesis. 3 Porcel JM,GasolA, BielsaS, Civit C, Light RW, Salud A. Clinical features and survival of lung cancer patients with pleural effusions.